This is an abstract of a poster in the new ATA Conference to be held later this year. It relates gastric pH to thyroid hormone uptake in humans.
GASTRIC PH AND ORAL THYROXINE REQUIREMENT: THE IN VIVO STUDY
C. Virili1, G. Bruno2, M. Santaguida1, B. Porowska3, C. De Vito4, C. Severi2, M. Centanni1
1Medico-Surgical Sciences and Biotechnologies, “Sapienza” University of Rome, Latina, Italy
2Department of Internal Medicine and Medical Specialties, “Sapienza” University of Rome, Rome, Italy
3Department of Cardio-Thoracic-Vascular Surgery and Organ Transplantation, “Sapienza” University of Rome, Roma, Italy
4Department of Public Health and Infectious Diseases, “Sapienza” University of Rome, Rome, Italy
An increased need for thyroxine has been observed in patients with H pylori related gastritis and gastric atrophy, disorders that may impair gastric acid secretion. In vitro evidence supports the notion that the variations of gastric pH may also interfere with T4 dissolution profile. This study was, therefore, designed to obtain the in vivo evidence of a direct correlation between the therapeutic dose of T4 and the gastric pH, directly measured during endoscopy. A total of 43 T4-treated hypothyroid patients (36W/7M; median age = 51yrs) have pledged to take thyroxine in fasting conditions, abstaining from eating or drinking for one hour. All patients underwent endoscopy with multiple biopsy specimens while gastric juice was collected for pH evaluation. To calculate the excess of T4 required in each patient, the individual dose of T4 was compared to the one observed in age- and BMI-matched patients but without gastrointestinal and/or pharmacological interference. The results were plotted against the actual pH and the H+ concentration titrated with NaOH-. To obtain a similar serum TSH (median = 1.11mU/l), the dose of thyroxine was progressively higher along with the increase of the gastric pH (r2 = 0.1209; p< 0.0223) and the actual H+ concentration (r2 = 0.1275;p< 0.0219). A multivariate analysis revealed that pH act as an independent variable in determining the dose of T4 (p < 0.029). Also, the excess of T4 dose (ED) required, plotted with gastric acidity in each patient, was highly correlated with the increased pH (p < 0.001) and decreased H+ concentration (p < 0.0001). Based on their pH, patients were then subdivided in two groups using as cut-off the median pH of the whole sample (2.4; IQ1-3 = 1.5-6.1). Only 6 out of 24 patients (25%) in group A (median pH = 1.52) needed a high T4 dose vs 17 out of 19 (89%;p<0.0001) in group B (median pH = 6.47). Overall, the median T4 dose was increased by 15% in group A and by 48% in group B. The ED of T4 was also differently distributed in patients with atrophic gastritis (90%), with pangastritis (73%) and with antritis (40%). This is the first in vivo study showing a positive correlation between gastric pH and the need for thyroxine in humans.